The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche; SERVIER; Synthon
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Inivata (Inst); Pfizer (Inst); Roche (Inst)
Predictors of prolonged benefit from palbociclib (PAL) plus fulvestrant (F) in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) advanced breast cancer (ABC) in PALOMA-3.
 
Massimo Cristofanilli
Honoraria - Agendia; Celgene; Dompé Farmaceutici; Pfizer
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics; Vortex Biosciences
 
Angela DeMichele
Honoraria - Pfizer
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Millennium (Inst); Pfizer (Inst); Veridex (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Carla Giorgetti
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Dennis J. Slamon
Leadership - Biomarin
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Biomarin; Pfizer
 
Seock-Ah Im
Consulting or Advisory Role - Hanmi; Novartis; Spectrum Pharmaceuticals
 
Norikazu Masuda
Honoraria - AstraZeneca; Chugai Pharma; Kyowa Hakko Kirin
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
 
Shailendra Verma
Consulting or Advisory Role - Pfizer
 
Sherene Loi
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices (Inst)
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology
 
Kathy Puyana Theall
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Honoraria - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Xin Huang
Employment - Pfizer
 
Cynthia Huang Bartlett
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Nicholas C. Turner
No Relationships to Disclose